According to IMARC Group’s latest report, titled “Meningococcal Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global meningococcal vaccines market to exhibit strong growth during the next five years.
The meningococcal vaccine includes a biological substance formulated to prevent meningitis that occurs when the liquid surrounding the brain and spinal cords become infected. The meningococcal vaccines can broadly be categorized into conjugate, polysaccharide, and subcapsular meningococcal vaccines. They are widely administered to infants, children and adults to immunize them against invasive ailments and meningococcal bacteria. Once the vaccine is dispensed, antibodies are formed to fight the bacteria and create an immune response to preclude the infection in the future.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/meningococcal-vaccines-market/requestsample
Market Trends
The growing prevalence of meningococcal diseases is primarily driving the market for meningococcal vaccines. Furthermore, the increasing health consciousness among the masses and the rising adoption of routine immunization are also positively influencing the market. The meningococcal vaccine helps in preventing the disease and minimizing the long-term effects, such as neurological damage, temporary or permanent deafness, and loss of vision and motor skills. Additionally, the government bodies across various nations are launching extensive public health programs for focusing on the immunization of special risk groups, such as tourists and military personnel, to contain the spread of infections. All of the above-mentioned factors will continue to drive the market for meningococcal vaccines in the coming years.
The report has segmented the market on the basis of vaccine type, composition, vaccine serotype, distribution channel, end-user and region.
Breakup by Vaccine Type:
Conjugate
Polysaccharide
Subcapsular
Breakup by Composition:
Mono Vaccines
Combination Vaccines
Breakup by Vaccine Serotype:
MenACWY
MenB & Manic
MenC
MenA
MenAC
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others
Breakup by End User:
Pediatric
Adult
For more information about this report: https://www.imarcgroup.com/meningococcal-vaccines-market
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: [email protected]
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group